These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Correction of enzymatic deficiencies by renal transplantation: fabry's disease. Najarian JS; Desnick RJ; Simmons RL; Krivit W Bull Soc Int Chir; 1975; 34(1):1-10. PubMed ID: 816478 [No Abstract] [Full Text] [Related]
4. [Renal transplantation in patients suffering from Fabry's disease. Kidney transplantation from an heterozygote subject to a subject without Fabry's disease]. Grünfeld JP; Le Porrier M; Droz D; Bensaude I; Hinglais N; Crosnier J Nouv Presse Med; 1975 Sep; 4(29):2081-5. PubMed ID: 809752 [TBL] [Abstract][Full Text] [Related]
5. Excellent outcome of renal transplantation in patients with Fabry's disease. Ojo A; Meier-Kriesche HU; Friedman G; Hanson J; Cibrik D; Leichtman A; Kaplan B Transplantation; 2000 Jun; 69(11):2337-9. PubMed ID: 10868636 [TBL] [Abstract][Full Text] [Related]
6. B.C.P. Jansen Institute, University of Amsterdam, Amsterdam, The Netherlands. Van den Bergh FA; Rietra PJ; Kolk-Vegter AJ; Bosch E; Tager JM Acta Med Scand; 1976; 200(4):249-56. PubMed ID: 824932 [TBL] [Abstract][Full Text] [Related]
7. Early renal failure in Fabry's disease. Sheth KJ; Roth DA; Adams MB Am J Kidney Dis; 1983 May; 2(6):651-4. PubMed ID: 6405613 [TBL] [Abstract][Full Text] [Related]
9. Identification of Fabry's disease by the screening of alpha-galactosidase A activity in male and female hemodialysis patients. Tanaka M; Ohashi T; Kobayashi M; Eto Y; Miyamura N; Nishida K; Araki E; Itoh K; Matsushita K; Hara M; Kuwahara K; Nakano T; Yasumoto N; Nonoguchi H; Tomita K Clin Nephrol; 2005 Oct; 64(4):281-7. PubMed ID: 16240899 [TBL] [Abstract][Full Text] [Related]
10. Residual activity of alpha-galactosidase A in Fabry's disease. Romeo G; D'Urso M; Pisacane A; Blum E; De Falco A; Ruffilli A Biochem Genet; 1975 Oct; 13(9-10):615-28. PubMed ID: 812485 [TBL] [Abstract][Full Text] [Related]
11. Properties of immobilized fig alpha-galactosidase and effect on ceramide-3 content of plasma from patients with Fabry's disease. Schram AW; Hamers MN; Oldenbroek-Haverkamp E; Strijland A; de Jonge A; van den Bergh FA; Tager JM Biochim Biophys Acta; 1978 Dec; 527(2):456-64. PubMed ID: 31916 [TBL] [Abstract][Full Text] [Related]
12. Deceased renal transplantation in patient with Fabry's disease maintained by enzyme replacement therapy. Kato T; Nishimura K; Ichikawa Y Int J Urol; 2009 Jul; 16(7):650. PubMed ID: 19659805 [No Abstract] [Full Text] [Related]